Incyte Corp (INCY)
72.04
+0.66
(+0.92%)
USD |
NASDAQ |
Feb 21, 15:58
Incyte Market Cap: 13.94B for Feb. 21, 2025
View 4,000+ Financial Data Types:
Add
Browse
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Exelixis Inc | 10.31B |
Syndax Pharmaceuticals Inc | 1.399B |
Blueprint Medicines Corp | 5.879B |
Biomarin Pharmaceutical Inc | 13.00B |
Halozyme Therapeutics Inc | 7.096B |
Market Cap Related Metrics
PE Ratio | 266.81 |
PS Ratio | 3.601 |
Price to Book Value | 4.044 |
Price to Free Cash Flow | 64.95 |
Price | 72.04 |
Earnings Yield | 0.37% |
Operating PE Ratio | 150.93 |
Normalized PE Ratio | 2222.70 |